Literature DB >> 16223657

Charlson's Index was a poor predictor of quality of life outcomes in a study of patients following joint replacement surgery.

Janis D Harse1, C D'Arcy J Holman.   

Abstract

OBJECTIVE: We examined the predictive validity of Charlson's Index as a tool to measure and adjust for comorbidity in studies of health-related quality of life(HRQOL) outcomes after joint replacement surgery. STUDY DESIGN AND
SETTING: SF-36 physical component summary scores were available for a cohort of patients who underwent primary hip or knee replacement surgery at one hospital over a 12-month period. Baseline comorbidity was assessed for the same group of patients using longitudinal hospital morbidity data from the Western Australia Department of Health. The presence or absence of individual conditions was determined, and Charlson's Index scores were calculated for each patient, using varying look-back periods.
RESULTS: In regression analysis, Charlson's Index was a poor predictor of the HRQOL outcome scores, explaining a maximum 1.79% of the variance. In contrast, the presence or absence of a small number of individual conditions together explained between 5% and 7% of the variance.
CONCLUSION: The findings suggest that Charlson's Index should not be used to adjust for HRQOL outcomes, particularly in this patient group with low levels of serious comorbidity. Alternative methods are needed for use in this context.

Entities:  

Mesh:

Year:  2005        PMID: 16223657     DOI: 10.1016/j.jclinepi.2005.02.017

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  9 in total

1.  Comorbidity scores reported in anatomic and reverse total shoulder arthroplasty: a systematic review.

Authors:  Joshua D Meade; Garrett R Jackson; Michael S Schallmo; Bradley Young; Robert L Parisien; David P Trofa; Patrick M Connor; Shadley Schiffern; Nady Hamid; Bryan M Saltzman
Journal:  Int Orthop       Date:  2022-06-06       Impact factor: 3.479

2.  Effects of Comorbidities on Pain and Function After Total Hip Arthroplasty.

Authors:  Pingwen Lan; Xi Chen; Zhi Fang; Jianjun Zhang; Shuping Liu; Yuehong Liu
Journal:  Front Surg       Date:  2022-05-11

3.  Predictors of health-related quality-of-life change after total hip arthroplasty.

Authors:  José M Quintana; Antonio Escobar; Urko Aguirre; Iratxe Lafuente; Juan C Arenaza
Journal:  Clin Orthop Relat Res       Date:  2009-05-02       Impact factor: 4.176

4.  Body mass index is not a clinically meaningful predictor of patient reported outcomes of primary hip replacement surgery: prospective cohort study.

Authors:  A Judge; R N Batra; G E Thomas; D Beard; M K Javaid; D W Murray; P A Dieppe; K E Dreinhoefer; K Peter-Guenther; R Field; C Cooper; N K Arden
Journal:  Osteoarthritis Cartilage       Date:  2014-01-11       Impact factor: 6.576

Review 5.  Evaluating comorbidities in total hip and knee arthroplasty: available instruments.

Authors:  Kristian Bjorgul; Wendy M Novicoff; Khaled J Saleh
Journal:  J Orthop Traumatol       Date:  2010-11-13

6.  Patterns of multimorbidity in working Australians.

Authors:  Paul A Scuffham; Michael F Hilton; Alexander Muspratt; Shu-Kay Ng; Harvey A Whiteford; Libby Holden
Journal:  Popul Health Metr       Date:  2011-06-02

7.  The association of patient characteristics and surgical variables on symptoms of pain and function over 5 years following primary hip-replacement surgery: a prospective cohort study.

Authors:  Andy Judge; Nigel K Arden; Rajbir N Batra; Geraint Thomas; David Beard; M Kassim Javaid; Cyrus Cooper; David Murray
Journal:  BMJ Open       Date:  2013-03-01       Impact factor: 2.692

8.  Increasing comorbidity is associated with worsening physical function and pain after primary total knee arthroplasty.

Authors:  Maren E Hilton; Terence Gioe; Siamak Noorbaloochi; Jasvinder A Singh
Journal:  BMC Musculoskelet Disord       Date:  2016-10-07       Impact factor: 2.362

9.  Measuring multimorbidity in hospitalised patients using linked hospital episode data: comparison of two measures.

Authors:  Lynn Robertson; Dolapo Ayansina; Marjorie Johnston; Angharad Marks; Corri Black
Journal:  Int J Popul Data Sci       Date:  2019-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.